Snyder Capital Management L P Increases Holdings in Henry Schein, Inc. $HSIC

by · The Cerbat Gem

Snyder Capital Management L P raised its stake in Henry Schein, Inc. (NASDAQ:HSIC – Free Report) by 18.6% in the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 1,334,364 shares of the company’s stock after buying an additional 209,123 shares during the quarter. Henry Schein makes up approximately 1.7% of Snyder Capital Management L P’s investment portfolio, making the stock its 18th largest position. Snyder Capital Management L P’s holdings in Henry Schein were worth $88,562,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors have also modified their holdings of the stock. AQR Capital Management LLC grew its holdings in shares of Henry Schein by 47.3% in the first quarter. AQR Capital Management LLC now owns 30,402 shares of the company’s stock valued at $2,071,000 after purchasing an additional 9,756 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its stake in shares of Henry Schein by 1.4% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 16,859 shares of the company’s stock valued at $1,155,000 after buying an additional 229 shares during the period. Acadian Asset Management LLC acquired a new stake in shares of Henry Schein during the 1st quarter worth approximately $676,000. Envestnet Asset Management Inc. raised its position in shares of Henry Schein by 103.1% during the 2nd quarter. Envestnet Asset Management Inc. now owns 91,299 shares of the company’s stock valued at $6,669,000 after buying an additional 46,357 shares during the period. Finally, Atria Investments Inc purchased a new position in Henry Schein in the second quarter worth approximately $458,000. Hedge funds and other institutional investors own 96.62% of the company’s stock.

Henry Schein Trading Up 0.5%

Shares of HSIC stock opened at $80.58 on Thursday. The company has a debt-to-equity ratio of 0.59, a quick ratio of 0.76 and a current ratio of 1.38. The stock has a market capitalization of $9.24 billion, a P/E ratio of 24.64, a price-to-earnings-growth ratio of 2.37 and a beta of 0.88. The company has a 50 day moving average price of $78.09 and a 200 day moving average price of $72.44. Henry Schein, Inc. has a fifty-two week low of $60.56 and a fifty-two week high of $89.29.

Henry Schein (NASDAQ:HSIC – Get Free Report) last released its earnings results on Tuesday, February 24th. The company reported $1.34 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.30 by $0.04. Henry Schein had a net margin of 3.02% and a return on equity of 15.16%. The company had revenue of $3.44 billion for the quarter, compared to analyst estimates of $3.34 billion. During the same period in the prior year, the business earned $1.19 EPS. The firm’s quarterly revenue was up 7.7% on a year-over-year basis. Henry Schein has set its FY 2026 guidance at 5.230-5.370 EPS. Equities research analysts predict that Henry Schein, Inc. will post 4.74 EPS for the current fiscal year.

Wall Street Analyst Weigh In

A number of equities research analysts have commented on HSIC shares. UBS Group lifted their target price on Henry Schein from $79.00 to $87.00 and gave the company a “neutral” rating in a research report on Wednesday, February 25th. Morgan Stanley increased their target price on shares of Henry Schein from $58.00 to $61.00 and gave the stock an “underweight” rating in a research note on Wednesday, February 25th. Evercore boosted their price target on shares of Henry Schein from $83.00 to $90.00 and gave the company an “outperform” rating in a research note on Wednesday, November 5th. Barrington Research set a $97.00 price objective on shares of Henry Schein and gave the stock an “outperform” rating in a research report on Wednesday, February 25th. Finally, Wells Fargo & Company boosted their target price on Henry Schein from $76.00 to $87.00 and gave the company an “equal weight” rating in a research report on Wednesday, February 25th. Six research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat, Henry Schein has a consensus rating of “Hold” and a consensus price target of $85.58.

Get Our Latest Stock Report on HSIC

Insider Activity

In related news, CEO Stanley M. Bergman sold 43,812 shares of Henry Schein stock in a transaction on Monday, March 2nd. The stock was sold at an average price of $81.31, for a total value of $3,562,353.72. Following the completion of the transaction, the chief executive officer directly owned 383,803 shares in the company, valued at approximately $31,207,021.93. This trade represents a 10.25% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Insiders sold 92,943 shares of company stock valued at $7,544,505 in the last 90 days. 1.08% of the stock is currently owned by company insiders.

Henry Schein Profile

(Free Report)

Henry Schein, Inc is a leading global distributor of healthcare products and services, primarily serving office-based dental, medical and animal health practitioners. The company operates through three principal segments—Schein Dental, Schein Medical and Animal Health—each offering a comprehensive portfolio of consumable products, equipment, instruments and related value-added services. With a focus on improving practice efficiency and patient care, Henry Schein provides everything from dental restorative materials and orthodontic appliances to vaccines, pharmaceuticals and diagnostic devices for physicians, as well as pet health products and veterinary equipment for animal health professionals.

In addition to its broad product offering, Henry Schein delivers a suite of technology and service solutions aimed at streamlining workflows and enhancing clinical outcomes.

See Also

Want to see what other hedge funds are holding HSIC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Henry Schein, Inc. (NASDAQ:HSIC – Free Report).